Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Trial compares targeted lung cancer treatments head-to-head
June 22, 2016
A world-first international clinical trial of two approved targeted therapies for advanced non-small-cell lung cancer showed the newer one significantly improves patient outcomes. The study compared gefitinib and afatinib, treatments that target a mutation of the epidermal growth factor receptor (EGFR) found in about 10 percent of NSCLC cases in North America. The randomized clinical trial involved 319 patients from 13 countries with late-stage NSCLC who had never been treated before. After two years of treatment, 17.6 percent of patients on afatinib were progression-free, versus 7.6 percent on gefitinib. In addition, 70 percent of patients on afatininb had their cancers shrink upon treatment compared to 56 percent of patients on gefitinib. Seven patients from The Ottawa Hospital participated in this study, and many more will likely benefit from this research. Dr.
Scott Laurie
was the local principal investigator for Ottawa and co-authored the study published in
Lancet Oncology
.
Local co-investigators:
Garth Nicholas, Paul Wheatley-Price, Martin Reaume, Glenwood Goss and David Stewart.
Funder:
Boehringer Ingelheim
The Ottawa Hospital: Inspired by research. Driven by compassion
The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care.
University of Ottawa
The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe. www.uottawa.ca
For further information, please contact
Amelia Buchanan
Senior Communication Specialist
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73687
Cell: 613-297-8315
ambuchanan@ohri.ca